BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND Ki-67
3697 results:

  • 1. In Vitro Investigation of Therapy-Induced Senescence and Senescence Escape in breast cancer Cells Using Novel Flow Cytometry-Based Methods.
    Tóth F; Moftakhar Z; Sotgia F; Lisanti MP
    Cells; 2024 May; 13(10):. PubMed ID: 38786063
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Lactylproteome analysis indicates histone H4K12 lactylation as a novel biomarker in triple-negative breast cancer.
    Cui Z; Li Y; Lin Y; Zheng C; Luo L; Hu D; Chen Y; Xiao Z; Sun Y
    Front Endocrinol (Lausanne); 2024; 15():1328679. PubMed ID: 38779451
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Retrospective analysis of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), Ki67 changes and their clinical significance between primary breast cancer and metastatic tumors.
    Qi G; Zhang X; Gai X; Yan X
    PeerJ; 2024; 12():e17377. PubMed ID: 38766488
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Axillary lymph node metastasis in pure mucinous carcinoma of breast: clinicopathologic and ultrasonographic features.
    Li N; Li JW; Qian Y; Liu YJ; Qi XZ; Chen YL; Gao Y; Chang C
    BMC Med Imaging; 2024 May; 24(1):108. PubMed ID: 38745134
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Correlation of ki-67 proliferative index with oncotype DX recurrence score in hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer with low-burden axillary nodal disease - a review of 137 cases.
    Saad Abdalla Al-Zawi A; Anichkina KA; Elamass M; Aladili Z
    Pol J Pathol; 2024; 75(1):8-18. PubMed ID: 38741425
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinicopathological characteristics and BRCA1/BRCA2 pathogenic variants of patients with breast cancer.
    Eras N; Tuncel F; Altıntas Z; Erden S
    Pol J Pathol; 2024; 75(1):1-7. PubMed ID: 38741424
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Outcome and Factors Related to Isolated Liver Metastasis due to breast cancer.
    Sen E; Canbak T; Bostanci O; Battal M
    J Coll Physicians Surg Pak; 2024 May; 34(5):604-609. PubMed ID: 38720224
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Artificial intelligence-powered optimization of ki-67 assessment in breast cancer: enhancing precision and workflow efficiency. a literature review.
    Mooghal M; Anjum S; Khan W; Tariq H; Babar A; Vohra LM
    J Pak Med Assoc; 2024 Apr; 74(4 (Supple-4)):S109-S116. PubMed ID: 38712418
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Association between pathological characteristics and recurrence score by OncotypeDX in resected T1-3 and N0-1 breast cancer: a real-life experience of a North Hungarian regional center.
    Deme D; Tamaskovics BF; Jammoul N; Kovács S; Kayode EO; Grice JW; Telekes A
    Pathol Oncol Res; 2024; 30():1611735. PubMed ID: 38689824
    [No Abstract]    [Full Text] [Related]  

  • 10. Lesion attention guided neural network for contrast-enhanced mammography-based biomarker status prediction in breast cancer.
    Qian N; Jiang W; Wu X; Zhang N; Yu H; Guo Y
    Comput Methods Programs Biomed; 2024 Jun; 250():108194. PubMed ID: 38678959
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. breast cancer in Patients with Previous Endometriosis Showed Low Aggressive Subtype.
    Vanni G; Selntigia A; Marsella VE; Russo C; Pellicciaro M; Materazzo M; Rizzo G; Buonomo OC; Exacoustos C
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674271
    [No Abstract]    [Full Text] [Related]  

  • 12. Prognostic Value of "Basal-like" Morphology, Tumor-Infiltrating Lymphocytes and Multi-MAGE-A Expression in Triple-Negative breast cancer.
    Čeprnja T; Tomić S; Perić Balja M; Marušić Z; Blažićević V; Spagnoli GC; Juretić A; Čapkun V; Vuger AT; Pogorelić Z; Mrklić I
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674098
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Analysis on status quo and related factors of delays in diagnosis and treatment of breast cancer in Ningxia Hui Autonomous Region.
    Wang Y; Bai Z; Liu Q; Yu H; Tang Z; Liu X; Liu Q
    Medicine (Baltimore); 2024 Apr; 103(17):e37826. PubMed ID: 38669416
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Impact of Pregnancy on breast cancer Features and Prognosis.
    Bounous VE; Minella C; Fuso L; Actis S; Petroni G; Sgrò LG; Borghese M; Tomasi Cont N; Ponzone R; Ferrero A
    Curr Oncol; 2024 Apr; 31(4):2305-2315. PubMed ID: 38668074
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Relationship between breast cancer Subtypes, Prognostic Factors, and Apparent Diffusion Coefficient Histogram Analysis.
    Aktas E; Uylar Seber T; Seber T; Burcek NV; Akay E; Arslan A; Karagöz Eren S; Ozhan N; Yaltırık Bilgin E; Savran B; Akdur P
    Curr Med Imaging; 2024; 20(1):e15734056271069. PubMed ID: 38616751
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The Predictive Role of Serum Lipid Levels, p53 and ki-67, According to Molecular Subtypes in breast cancer: A Randomized Clinical Study.
    Faur IF; Dobrescu A; Clim IA; Pasca P; Prodan-Barbulescu C; Tarta C; Neamtu AA; Brebu D; Neamtu C; Rosu M; Duta C; Clim A; Lazar G; Totolici B
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612725
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Machine Learning Prediction of Lymph Node Metastasis in breast cancer: Performance of a Multi-institutional MRI-based 4D Convolutional Neural Network.
    Polat DS; Nguyen S; Karbasi P; Hulsey K; Cobanoglu MC; Wang L; Montillo A; Dogan BE
    Radiol Imaging Cancer; 2024 May; 6(3):e230107. PubMed ID: 38607282
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. U2AF2-SNORA68 promotes triple-negative breast cancer stemness through the translocation of RPL23 from nucleoplasm to nucleolus and c-Myc expression.
    Zhang W; Song X; Jin Z; Zhang Y; Li S; Jin F; Zheng A
    Breast Cancer Res; 2024 Apr; 26(1):60. PubMed ID: 38594783
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Comparative immunohistochemistry study of different antibodies clones for detection of breast cancer markers (estrogen receptor, progesterone receptor, HER2/neu, ki-67)].
    Kalinin DV; Samoylova DV; Danilova NV; Germanovich NY; Kuznetsova OA; Zavalishina LE
    Arkh Patol; 2024; 86(2):14-20. PubMed ID: 38591902
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prevalence of metastases outside the liver and abdominal lymph nodes on
    Wedin M; Janson ET; Wallin G; Sundin A; Daskalakis K
    J Neuroendocrinol; 2024 May; 36(5):e13391. PubMed ID: 38590270
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 185.